Visuospatial working memory in behavioural variant frontotemporal dementia: a comparative analysis with Alzheimer's disease using the box task David FoxeMuireann IrishOlivier Piguet Original Communication Open access 07 May 2024
Motor function in multiple sclerosis assessed by navigated transcranial magnetic stimulation mapping Benjamin BardelAlain CréangeJean-Pascal Lefaucheur Original Communication 06 May 2024
Heterogeneity of cognitive impairments in myotonic dystrophy type 1 explained by three distinct cognitive profiles Jean-Baptiste DavionCéline TardXavier Delbeuck Original Communication 06 May 2024
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study Aurora ZanghìGiovanna BorrielloEmanuele D’Amico Original Communication Open access 04 May 2024
Cerebellar encephalitis and peripheral neuropathy with an atypical clinical and neuroimaging signature following Covid-19 vaccine: a report of two cases Marin SicardNatalia ShorDario Saracino Letter to the Editors 04 May 2024
Correlation between severe attacks and serum aquaporin-4 antibody titer in neuromyelitis optica spectrum disorder Rui WangDongren SunHongyu Zhou Original Communication 04 May 2024
Is there a spinal tap responder in progressive supranuclear palsy? The first prospective study Masahiro OharaTakaaki HattoriTakanori Yokota Original Communication 03 May 2024
Evaluation of a multimodal diagnostic algorithm for prediction of cognitive impairment in elderly patients with dizziness K. FelfelaN. JooshaniA. Zwergal Original Communication Open access 03 May 2024
Gait and heart rate: do they measure trait or state physical fatigue in people with multiple sclerosis? Irina GalperinDavid BuzagloJeffrey M. Hausdorff Original Communication Open access 02 May 2024
Large phenotypic diversity by genotype in patients with GNE myopathy: 10 years after the establishment of a national registry in Japan Wakako YoshiokaHarumasa NakamuraMadoka Mori-Yoshimura Original Communication 01 May 2024
Advanced neuroimaging techniques to explore the effects of motor and cognitive rehabilitation in multiple sclerosis Maria A. RoccaFrancesco RomanòMassimo Filippi Review 01 May 2024
Management of multiple sclerosis in older adults: review of current evidence and future perspectives Kimberly A. DiMauroCarol SwetlikJeffrey A. Cohen Review Open access 30 April 2024
Diagnostic value of neurofilaments in differentiating motor neuron disease from multifocal motor neuropathy Camilla WohnradeTabea SeeligerSusanne Petri Original Communication Open access 29 April 2024
Chronic basilar artery occlusion: a retrospective monocentric study Christian RothRosa YavuzJohannes Matthaei Original Communication 27 April 2024
Traumatic brain injury incidence and mortality: a large population-based study Claudio Barbiellini AmideiLaura SalmasoMario Saia Original Communication 27 April 2024
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis Igal RosensteinAnna NordinLenka Novakova Original Communication Open access 26 April 2024
Rafael Lorente de Nó (1902–1990) Juan Manuel Espinosa-SanchezNicolas Perez-FernandezAngel Batuecas-Caletrio Pioneers in Neurology 24 April 2024
Outcomes of mechanical thrombectomy in patients with acute ischemic stroke and thrombocytopenia: systematic review and meta-analysis Michelle A. TorunoOmar M. Al-JanabiDavid F. Kallmes Original Communication 24 April 2024
Rituximab in non-systemic vasculitic neuropathy: a single-center experience Felix KohleGilbert WunderlichChristian Schneider Original Communication Open access 24 April 2024
Seizures in autoimmune-associated epilepsy: a long-term video-EEG monitoring study Joana FonteAndrea StabileFrancesco Deleo Letter to the Editors 24 April 2024
GBA moderates cognitive reserve's effect on cognitive function in patients with Parkinson's disease Chia-Wen ChangChun-Hsiang TanRwei-Ling Yu Original Communication 24 April 2024
Neuropsychiatric complications of coronavirus disease 2019: Mount Sinai Health System cohort study Kapil GururanganVeronica J. Peschanskyfor the Sinai NeuroCOVID-19 Study Group Original Communication 24 April 2024
Sleep characteristics and risk of Alzheimer’s disease: a systematic review and meta-analysis of longitudinal studies Shichan WangXiaoting ZhengHuifang Shang Review 24 April 2024
Improved quality of life and psychological symptoms following mindfulness and cognitive rehabilitation in multiple sclerosis and their mediating role for cognition: a randomized controlled trial Ilse M. NautaMaureen van DamBrigit A. de Jong Original Communication Open access 23 April 2024
Gait asymmetry and symptom laterality in Parkinson’s disease: two of a kind? Jana SeutheHelen HermannsChristian Schlenstedt Original Communication Open access 23 April 2024
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial Hans-Peter HartungThomas BergerMark S. Freedman Original Communication Open access 22 April 2024
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules Elena NiccolaiMatteo PedoneAmedeo Amedei Original Communication Open access 21 April 2024
Non-invasive biomarkers for spontaneous intracranial hypotension (SIH) through phase-contrast MRI Katharina WolfFlorian VolzHorst Urbach Original Communication Open access 21 April 2024
Age-specific prevalence of the different clinical presentations of AD and FTD in young-onset dementia Giovanna ZamboniRiccardo MaramottiAnnalisa Chiari Original Communication Open access 21 April 2024
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings Claudia PestchankerBrenda Bertado CortezEdgar Carnero Contentti Original Communication 17 April 2024
Frontal hypometabolism in the diagnosis of progressive supranuclear palsy clinical variants Jack A. BlackNha Trang Thu PhamJennifer L. Whitwell Original Communication 17 April 2024
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications Antonio Luca SpieziaGiulia ScaliaAntonio Carotenuto Original Communication Open access 17 April 2024
Respiratory comorbidities and treatments in Duchenne muscular dystrophy: impact on life expectancy and causes of death Lisa WahlgrenAnna-Karin KroksmarkKalliopi Sofou Original Communication Open access 17 April 2024
Genetic diagnosis and detection rates using C9orf72 repeat expansion and a multi-gene panel in amyotrophic lateral sclerosis Dalit BarelDaphna MaromHagit Baris Feldman Original Communication 16 April 2024
Clinical trial evidence of quality-of-life effects of disease-modifying therapies for multiple sclerosis: a systematic analysis Julian HirtKinga DembowskaPerrine Janiaud Review Open access 16 April 2024
TMS of the left primary motor cortex improves tremor intensity and postural control in primary orthostatic tremor Florian SchoeberlJames DowsettAndreas Zwergal Original Communication Open access 16 April 2024
Which parameters influence cognitive, psychiatric and long-term seizure outcome in mesial temporal lobe epilepsy after selective amygdalohippocampectomy? Judith JudHarald StefanitsEkaterina Pataraia Original Communication Open access 15 April 2024
Applying the 2022 optic neuritis criteria to noninflammatory optic neuropathies with optic nerve T2-hyperintensity: an observational study Fernando Labella ÁlvarezValérie BiousseNancy J. Newman Original Communication 15 April 2024
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption Barry A. SingerJenny FengHoracio Chiong-Rivero Review Open access 14 April 2024
Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials A. E. GuiloffP. Rudge Journal club Open access 13 April 2024 Pages: 2914 - 2916
Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity—a potential diagnostic pitfall in patients with MOG-EM/MOGAD S. JariusM. RingelsteinB. Wildemann Letter to the Editors Open access 13 April 2024
Healthy blood, healthy brain: a window into understanding and treating neurodegenerative diseases Thyago R. Cardim-PiresAurélie de Rus JacquetFrancesca Cicchetti Neurological Update 12 April 2024
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson’s disease patients Claudia LeddaAlberto RomagnoloMaurizio Zibetti Short Commentary 12 April 2024
The role of language-related functional brain regions and white matter tracts in network plasticity of post-stroke aphasia Yue HanYuanyuan JingFang Deng Review 12 April 2024
Accuracy of routinely collected hospital administrative discharge data and death certificate ICD-10 diagnostic coding in progressive supranuclear palsy and corticobasal syndrome: a systematic review and validation study Diane M. A. SwallowCarl E. Counsell Original Communication Open access 12 April 2024
A survey-based approach on restless legs syndrome: practices and perspectives among Italian neurologists Elena AntelmiGloria Pompea MingollaMichele Tinazzi Original Communication 12 April 2024
Channelopathies in epilepsy: an overview of clinical presentations, pathogenic mechanisms, and therapeutic insights Andy Cheuk-Him NgMohamed ChahineJuan P. Appendino Review 12 April 2024
Exosomes for neurodegenerative diseases: diagnosis and targeted therapy Hui TaoBo Gao Review 12 April 2024
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report Yong ZhangDan LiuGuiyun Cui Letter to the Editors 11 April 2024
